Analyst Reco. Eli Lilly and Company

Equities

LLY

US5324571083

Real-time Estimate Cboe BZX Other stock markets 09:45:21 2024-05-03 am EDT			5-day change	1st Jan Change
739 ^USD	-2.24%		+4.28%	+29.68%

03:16pm	News Highlights : Top Company News of the Day - Friday at 9 AM ET	DJ
02:58pm	Wall St set to open sharply higher on soft jobs data	RE

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JPMorgan Adjusts Price Target on Eli Lilly to $900 From $850	May. 01	MT
Wolfe Research Adjusts Price Target on Eli Lilly to $909 From $813	May. 01	MT
Barclays Adjusts Price Target on Eli Lilly and Company to $913 From $810	May. 01	MT
BMO Capital Adjusts Eli Lilly Price Target to $1,001 From $900	May. 01	MT
Leerink Partners Adjusts Price Target on Eli Lilly to $901 From $821	May. 01	MT
Deutsche Bank Adjusts Price Target on Eli Lilly to $725 From $695	May. 01	MT
Truist Raises Price Target on Eli Lilly to $892 From $850, Keeps Buy Rating	May. 01	MT
Goldman Sachs Adjusts Price Target on Eli Lilly to $740 From $723	May. 01	MT
Wells Fargo Adjusts Eli Lilly Price Target to $875 From $825	May. 01	MT
Morgan Stanley Raises Price Target on Eli Lilly to $1,023 From $950 Amid 2024 Guidance Boost, Keeps Overweight Rating	May. 01	MT
Jefferies Adjusts Eli Lilly and Co.'s Price Target to $915 From $895, Keeps Buy Rating	Apr. 30	MT
Jefferies Raises Eli Lilly's Price Target to $895 From $885, Buy Rating Kept	Apr. 17	MT
BMO Raises Price Target on Eli Lilly to $900 From $865	Apr. 12	MT
Western Drugmakers Seeking Alternative Suppliers as US Looks to Restrict Chinese Biotech	Apr. 11	MT
Goldman Sachs Raises Price Target on Eli Lilly to $723 From $650, Maintains Neutral Rating	Apr. 11	MT
Western Drugmakers Seeking Alternative Suppliers as US Looks to Restrict Chinese Biotech	Apr. 11	MT
ANALYST RECOMMENDATIONS : Estee Lauder, Humana, Eli Lilly, National Grid, Brown-Forman...	Apr. 02
Top Midday Stories: Bankman-Fried Gets 25-Year Prison Sentence; Home Depot Acquiring SRS Distribution; Walgreens Lowers FY 2024 Outlook; Analyst Says Short MicroStrategy; Canadian School Boards Sue Social Media Platforms; Eli Lilly Weight-Loss Drug Facing Shortage	Mar. 28	MT
JPMorgan Raises Eli Lilly's Price Target to $850 From $775, Maintains Overweight Rating	Mar. 15	MT
UBS Adjusts Eli Lilly Price Target to $910 From $810, Maintains Buy Rating	Mar. 04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 02:47 pm EDT